OPKO Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on August 19, 2013. The report addresses a corporate event regarding the expansion of the company's stock listing.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the approval by the Tel-Aviv Stock Exchange (TASE) for the new listing of OPKO Health's common stock. The listing commenced on August 21, 2013, under the ticker symbol "OPK". Consequently, the company's stock is listed on both the New York Stock Exchange (NYSE) and the TASE.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, risk factors, contingencies, or unusual items beyond the announcement of the dual listing.
Key Facts for Investors to Verify
- Confirmation of the TASE listing start date of August 21, 2013.
- Verification of the ticker symbol "OPK" on the Tel-Aviv Stock Exchange.
- Review of the attached press release (Exhibit 99.1) for additional details on the listing process.